Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Development and Efficacy of a Novel Bromodomain and Extraterminal Domain Degrader K-256 in MYC/BCL2-Related Lymphoma

Kastuya Furukawa, Kazuyuki Shimada, Masahiro Esaki, Kentaro Tanaka, Keisuke Yamamoto, Kiyotoshi Mori, Hitoshi Kiyoi

Blood (2023) 142 (Supplement 1): 5008.

https://doi.org/10.1182/blood-2023-179334

Published: 2023

Journal Articles

Impact of Progression-Free Survival at 24 Months on Subsequent Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Supplementary Analysis of JCOG0601

Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa, Tomotaka Suzuki, Kazuyuki Shimada, Tsutomu Kobayashi, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Dai Maruyama, Hirokazu Nagai

Blood (2023) 142 (Supplement 1): 4499.

https://doi.org/10.1182/blood-2023-173433

Published: 2023

Journal Articles

The Prognostic Impact of Relative Dose Intensity of Vincristine in R-CHOP for Untreated Patients with Diffuse Large B-Cell Lymphoma: A Supplementary Analysis of JCOG0601

Takahiro Nakashima, Tomotaka Suzuki, Gakuto Ogawa, Kazuyuki Shimada, Tsutomu Kobayashi, Dai Maruyama, Wataru Munakata, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Hirokazu Nagai

Blood (2023) 142 (Supplement 1): 1741.

https://doi.org/10.1182/blood-2023-174354

Published: 2023

Journal Articles

Efficacy and Safety of Zanubrutinib in Japanese Patients with Mature B-Cell Malignancies

Blood (2022) 140 (Supplement 1): 3663–3665.

https://doi.org/10.1182/blood-2022-168696

Published: 2022

Journal Articles

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2022) 140 (Supplement 1): 11890–11892.

https://doi.org/10.1182/blood-2022-164977

Published: 2022

Journal Articles

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Takashi Watanabe, Kensei Tobinai, Ｍasashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, Michinori Ogura, Junya Kuroda, Youko Suehiro, Yoshihiro Matsuno, Kunihiro Tsukasaki, Hirokazu Nagai

Blood (2022) 140 (Supplement 1): 3615–3617.

https://doi.org/10.1182/blood-2022-159967

Published: 2022

Journal Articles

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2021) 138 (Supplement 1): 2451.

https://doi.org/10.1182/blood-2021-146340

Published: 2021

Journal Articles

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Blood (2021) 137 (11): 1491–1502.

https://doi.org/10.1182/blood.2020007245

Published: 2021

Includes: Supplemental data

Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Blood (2019) 134 (Supplement_1): 350.

https://doi.org/10.1182/blood-2019-126798

Published: 2019

Journal Articles

Exosomes Derived from Cancer Associated Fibroblasts Elicit Survival and Drug Resistance of Primary Lymphoma Cells

Shunsuke Kunou, Kazuyuki Shimada, MD PhD, Tomoya Hikita, PhD, Tomohiro Aoki, MD PhD, Akihiko Sakamoto, PhD, Fumihiko Hayakawa, MD, PhD, Chitose Oneyama, PhD, Hitoshi Kiyoi, MD PhD

Blood (2018) 132 (Supplement 1): 4128.

https://doi.org/10.1182/blood-2018-99-111863

Published: 2018

Journal Articles

Biology and management of primary effusion lymphoma

Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi

Blood (2018) 132 (18): 1879–1888.

https://doi.org/10.1182/blood-2018-03-791426

Published: 2018

Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Blood (2017) 130 (Supplement 1): 4127.

https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127

Published: 2017

Journal Articles

A Novel Prognostic Model for Primary Gastric Diffuse Large B-Cell Lymphoma in the Rituximab Era, Integrating EBV Harboring on Tumor Cells

Eri Ishikawa, MD, Tsutomu Tanaka, Kazuyuki Shimada, MD, Hidemi Goto, Shigeo Nakamura, MD PhD, Seiichi Kato

Blood (2017) 130 (Supplement 1): 2836.

https://doi.org/10.1182/blood.V130.Suppl_1.2836.2836

Published: 2017

Journal Articles

Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA

Akihiro Tomita, MDPhD, Kazuyuki Shimada, MD, Kenichi Yoshida, MD PhD, Yasuhiro Suzuki, MD PhD, Chisako Iriyama, MD PhD, Masashi Sanada, MD PhD, Masaaki Yuge, MD PhD, Yusuke Takagi, MD PhD, Shigeru Kusumoto, MD, Yasufumi Masaki, MD PhD, Takahiko Ito, MD PhD, Yuichiro Inagaki, MD PhD, Akinao Okamoto, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, B.A., Hiroko Tanaka, B.A., Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2017) 130 (Supplement 1): 1452.

https://doi.org/10.1182/blood.V130.Suppl_1.1452.1452

Published: 2017

Journal Articles

Emetine Elicits Apoptosis of Intractable B-Cell Lymphoma Cells with MYC Rearrangement through Inhibition of Glycolytic Metabolism

Tomohiro Aoki, MD, Kazuyuki Shimada, MD PhD, Akihiko Sakamoto, PhD, Keiki Sugimoto, PhD, Takanobu Morishita, MD, Yuki Kojima, MD, Satoko Shimada, MD PhD, Seiichi Kato, MD PhD, Chisako Iriyama, MD PhD, Shunsuke Kuno, MD, Yasuhiko Harada, MD, Shigeo Nakamura, MD PhD, Akihiro Tomita, MD PhD, Fumihiko Hayakawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2016) 128 (22): 3019.

https://doi.org/10.1182/blood.V128.22.3019.3019

Published: 2016

Journal Articles

Utilization of Peripheral Blood Cell-Free DNA in Myelodysplastic Syndromes: Clinical and Molecular Characteristics and Utilization for Genetic Analyses Using Conventional and Next-Generation Strategies

Akihiro Tomita, MD PhD, Yasuhiro Suzuki, MD, Fumika Nakamura, Chisako Iriyama, MD PhD, Mizuho Shirahata-Adachi, MD, Kazuyuki Shimada, MD PhD, Akimi Akashi, Yuichi Ishikawa, MDPhD, Norio Kaneda, PhD, Hitoshi Kiyoi, MD PhD

Blood (2015) 126 (23): 4102.

https://doi.org/10.1182/blood.V126.23.4102.4102

Published: 2015

Journal Articles

Effects of Daily Aspirin on Cancer Incidence and Mortality in the Japanese

Kenji Yokoyama, MD PhD, Naoki Ishizuka, PhD, Naomi Uemura, MD PhD, Yuji Mizokami, MD PhD, Hideyuki Hiraishi, MD PhD, Tamio Teramoto, MD PhD, Kazuyuki Shimada, MD PhD, Yasuo Ikeda, MD PhD

Blood (2015) 126 (23): 2322.

https://doi.org/10.1182/blood.V126.23.2322.2322

Published: 2015

Journal Articles

Development and Analysis of Novel Intravascular Large B-Cell Lymphoma NOD/Shi- Scid IL2Rγ null Mouse Xenograft Model

Kazuyuki Shimada, MD PhD, Satoko Shimada, MD PhD, Keiki Sugimoto, Fumihiko Hayakawa, MD PhD, Miyuki Katayama, MD PhD, Akihiro Hirakawa, PhD, Yusuke Takagi, MD, Shigeo Nakamura, MD PhD, Masao Seto, MD PhD, Tomoki Naoe, MDPhD, Akihiro Tomita, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2014) 124 (21): 497.

https://doi.org/10.1182/blood.V124.21.497.497

Published: 2014

Journal Articles

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Yasuhiro Suzuki, MD, Akihiro Tomita, MD PhD, Kenichi Yoshida, MD PhD, Kazuyuki Shimada, MD PhD, Chisako Iriyama, MD PhD, Masashi Sanada, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2014) 124 (21): 1658.

https://doi.org/10.1182/blood.V124.21.1658.1658

Published: 2014

Journal Articles

Anti-CD20 Chimeric Antigen Receptor Transduced T Cells Can Recognize Very Low Antigen Expression: Determination Of The Lower Threshold Required To Activate The CAR-T Cells

Keisuke Watanabe, MD, Seitaro Terakura, MD, PhD, Tatsunori Goto, MD, Ryo Hanajiri, MD, Nobuhiko Imahashi, MD, Kazuyuki Shimada, M.D., Ph.D., Tetsuya Nishida, MD, PhD, Akihiro Tomita, MD, PhD, Makoto Murata, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2013) 122 (21): 4493.

https://doi.org/10.1182/blood.V122.21.4493.4493

Published: 2013

NARROW

Development and Efficacy of a Novel Bromodomain and Extraterminal Domain Degrader K-256 in MYC/BCL2-Related Lymphoma

Impact of Progression-Free Survival at 24 Months on Subsequent Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Supplementary Analysis of JCOG0601

The Prognostic Impact of Relative Dose Intensity of Vincristine in R-CHOP for Untreated Patients with Diffuse Large B-Cell Lymphoma: A Supplementary Analysis of JCOG0601

Efficacy and Safety of Zanubrutinib in Japanese Patients with Mature B-Cell Malignancies

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Exosomes Derived from Cancer Associated Fibroblasts Elicit Survival and Drug Resistance of Primary Lymphoma Cells

Biology and management of primary effusion lymphoma

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

A Novel Prognostic Model for Primary Gastric Diffuse Large B-Cell Lymphoma in the Rituximab Era, Integrating EBV Harboring on Tumor Cells

Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA

Emetine Elicits Apoptosis of Intractable B-Cell Lymphoma Cells with MYC Rearrangement through Inhibition of Glycolytic Metabolism

Utilization of Peripheral Blood Cell-Free DNA in Myelodysplastic Syndromes: Clinical and Molecular Characteristics and Utilization for Genetic Analyses Using Conventional and Next-Generation Strategies

Effects of Daily Aspirin on Cancer Incidence and Mortality in the Japanese

Development and Analysis of Novel Intravascular Large B-Cell Lymphoma NOD/Shi- Scid IL2Rγ null Mouse Xenograft Model

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Anti-CD20 Chimeric Antigen Receptor Transduced T Cells Can Recognize Very Low Antigen Expression: Determination Of The Lower Threshold Required To Activate The CAR-T Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only